{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T03:52:00Z","timestamp":1792036320872,"version":"4.4.0"},"reference-count":67,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,3,1]],"date-time":"2016-03-01T00:00:00Z","timestamp":1456790400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100003035","name":"Aase og Ejner Danielsens Fond","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100003035","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","jns-journal.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the Neurological Sciences"],"published-print":{"date-parts":[[2016,3]]},"DOI":"10.1016\/j.jns.2016.02.018","type":"journal-article","created":{"date-parts":[[2016,2,9]],"date-time":"2016-02-09T19:01:07Z","timestamp":1455044467000},"page":"326-332","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"special_numbering":"C","title":["Liver function in Huntington's disease assessed by blood biochemical analyses in a clinical setting"],"prefix":"10.1016","volume":"362","author":[{"given":"Signe Marie Borch","family":"Nielsen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tua","family":"Vinther-Jensen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00f8rgen E.","family":"Nielsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"N\u00f8rrem\u00f8lle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lis","family":"Hasholt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lena E.","family":"Hjermind","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Knud","family":"Josefsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.jns.2016.02.018_bb0005","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1177\/0891988710383573","article-title":"The clinical and genetic features of Huntington disease","volume":"23","author":"Sturrock","year":"2010","journal-title":"J. Geriatr. Psychiatry Neurol."},{"issue":"6","key":"10.1016\/j.jns.2016.02.018_bb0010","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/0092-8674(93)90585-E","article-title":"A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes. The Huntington's Disease Collaborative Research Group","volume":"72","author":"Group","year":"1993","journal-title":"Cell"},{"key":"10.1016\/j.jns.2016.02.018_bb0015","doi-asserted-by":"crossref","unstructured":"Marques Sousa C. and S. Humbert, Huntingtin: here, there, everywhere!.J. Huntingtons Dis., 2013. 2(4): p. 395\u2013403.","DOI":"10.3233\/JHD-130082"},{"issue":"8","key":"10.1016\/j.jns.2016.02.018_bb0020","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1016\/S1474-4422(09)70178-4","article-title":"Beyond the brain: widespread pathology in Huntington's disease","volume":"8","author":"van der Burg","year":"2009","journal-title":"Lancet Neurol."},{"issue":"2","key":"10.1016\/j.jns.2016.02.018_bb0025","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/j.expneurol.2009.05.012","article-title":"Huntington's disease: the current state of research with peripheral tissues","volume":"219","author":"Sassone","year":"2009","journal-title":"Exp. Neurol."},{"issue":"9","key":"10.1016\/j.jns.2016.02.018_bb0030","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1212\/01.WNL.0000031791.10922.CF","article-title":"Weight loss in early stage of Huntington's disease","volume":"59","author":"Djousse","year":"2002","journal-title":"Neurology"},{"issue":"19","key":"10.1016\/j.jns.2016.02.018_bb0035","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1212\/01.wnl.0000334276.09729.0e","article-title":"Weight loss in Huntington disease increases with higher CAG repeat number","volume":"71","author":"Aziz","year":"2008","journal-title":"Neurology"},{"issue":"3","key":"10.1016\/j.jns.2016.02.018_bb0040","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/S0092-8674(00)81369-0","article-title":"Exon 1 of the HD gene with an expanded CAG repeat is sufficient to cause a progressive neurological phenotype in transgenic mice","volume":"87","author":"Mangiarini","year":"1996","journal-title":"Cell"},{"issue":"3","key":"10.1016\/j.jns.2016.02.018_bb0045","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.nbd.2009.05.007","article-title":"Systematic behavioral evaluation of Huntington's disease transgenic and knock-in mouse models","volume":"35","author":"Menalled","year":"2009","journal-title":"Neurobiol. Dis."},{"issue":"4","key":"10.1016\/j.jns.2016.02.018_bb0050","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1016\/j.neuroscience.2003.08.053","article-title":"Molecular and behavioral analysis of the R6\/1 Huntington's disease transgenic mouse","volume":"122","author":"Naver","year":"2003","journal-title":"Neuroscience"},{"issue":"11","key":"10.1016\/j.jns.2016.02.018_bb0055","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1136\/jnnp.2009.191833","article-title":"Systemic energy homeostasis in Huntington's disease patients","volume":"81","author":"Aziz","year":"2010","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"issue":"2","key":"10.1016\/j.jns.2016.02.018_bb0060","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1016\/j.expneurol.2007.12.026","article-title":"The metabolic profile of early Huntington's disease\u2014a combined human and transgenic mouse study","volume":"210","author":"Goodman","year":"2008","journal-title":"Exp. Neurol."},{"issue":"5","key":"10.1016\/j.jns.2016.02.018_bb0065","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1093\/hmg\/ddl481","article-title":"Dysregulation of C\/EBPalpha by mutant Huntingtin causes the urea cycle deficiency in Huntington's disease","volume":"16","author":"Chiang","year":"2007","journal-title":"Hum. Mol. Genet."},{"issue":"9","key":"10.1016\/j.jns.2016.02.018_bb0070","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1016\/j.bbadis.2011.05.006","article-title":"The dysfunction of hepatic transcriptional factors in mice with Huntington's Disease","volume":"1812","author":"Chiang","year":"2011","journal-title":"Biochim. Biophys. Acta Mol. basis Dis."},{"issue":"16","key":"10.1016\/j.jns.2016.02.018_bb0075","doi-asserted-by":"crossref","first-page":"3190","DOI":"10.1093\/hmg\/ddq229","article-title":"Impairment of PGC-1alpha expression, neuropathology and hepatic steatosis in a transgenic mouse model of Huntington's disease following chronic energy deprivation","volume":"19","author":"Chaturvedi","year":"2010","journal-title":"Hum. Mol. Genet."},{"issue":"20","key":"10.1016\/j.jns.2016.02.018_bb0080","doi-asserted-by":"crossref","first-page":"4043","DOI":"10.1093\/hmg\/ddq322","article-title":"Modulation of energy deficiency in Huntington's disease via activation of the peroxisome proliferator-activated receptor gamma","volume":"19","author":"Chiang","year":"2010","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.jns.2016.02.018_bb0085","series-title":"Huntington's Disease, in Genetic Instabilities and Neurological Diseases","first-page":"301","author":"M.K.","year":"1998"},{"issue":"6","key":"10.1016\/j.jns.2016.02.018_bb0090","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1002\/mds.25862","article-title":"Progressive hepatic mitochondrial dysfunction in premanifest Huntington's disease","volume":"29","author":"Hoffmann","year":"2014","journal-title":"Mov. Disord."},{"issue":"8","key":"10.1016\/j.jns.2016.02.018_bb0095","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1212\/WNL.0b013e318282514e","article-title":"Hepatic mitochondrial dysfunction in manifest and premanifest Huntington disease","volume":"80","author":"Stuwe","year":"2013","journal-title":"Neurology"},{"issue":"3","key":"10.1016\/j.jns.2016.02.018_bb0100","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1016\/j.nbd.2010.08.009","article-title":"Reduced gluconeogenesis and lactate clearance in Huntington's disease","volume":"40","author":"Josefsen","year":"2010","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.jns.2016.02.018_bb0105","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1186\/s13023-014-0114-8","article-title":"A clinical classification acknowledging neuropsychiatric and cognitive impairment in Huntington's disease","volume":"9","author":"Vinther-Jensen","year":"2014","journal-title":"Orphanet. J. Rare Dis."},{"issue":"2","key":"10.1016\/j.jns.2016.02.018_bb0110","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1002\/mds.870110204","volume":"11","year":"1996","journal-title":"Mov. Disord."},{"issue":"7","key":"10.1016\/j.jns.2016.02.018_bb0115","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1097\/PAT.0b013e32834bf5f4","article-title":"Laboratory testing of anticoagulants: the present and the future","volume":"43","author":"Favaloro","year":"2011","journal-title":"Pathology"},{"issue":"10","key":"10.1016\/j.jns.2016.02.018_bb0120","first-page":"6193","article-title":"Modulation of gamma-glutamyl transpeptidase activity by bile acids","volume":"258","author":"Abbott","year":"1983","journal-title":"J. Biolumin. Chemilumin."},{"issue":"2","key":"10.1016\/j.jns.2016.02.018_bb0125","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1007\/s11938-001-0022-6","article-title":"Hyperlipidemia in chronic cholestatic liver disease","volume":"4","author":"Longo","year":"2001","journal-title":"Curr. Treat. Options Gastroenterol."},{"issue":"3","key":"10.1016\/j.jns.2016.02.018_bb0130","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1038\/clpt.2012.108","article-title":"Alanine aminotransferase: a clinical and regulatory tool for detecting liver injury\u2014past, present, and future","volume":"92","author":"Senior","year":"2012","journal-title":"Clin. Pharmacol. Ther."},{"issue":"1","key":"10.1016\/j.jns.2016.02.018_bb0135","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.mcna.2013.09.005","article-title":"Evaluation of abnormal liver tests","volume":"98","author":"Woreta","year":"2014","journal-title":"Med. Clin. North Am."},{"issue":"1","key":"10.1016\/j.jns.2016.02.018_bb0140","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1161\/01.ATV.0000148324.63685.6a","article-title":"Association between elevated liver enzymes and C-reactive protein: possible hepatic contribution to systemic inflammation in the metabolic syndrome","volume":"25","author":"Kerner","year":"2005","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"4\u20135","key":"10.1016\/j.jns.2016.02.018_bb0145","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/j.autrev.2013.11.009","article-title":"Diagnostic criteria of autoimmune hepatitis","volume":"13","author":"Liberal","year":"2014","journal-title":"Autoimmun. Rev."},{"issue":"2","key":"10.1016\/j.jns.2016.02.018_bb0150","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1053\/j.gastro.2003.10.065","article-title":"Diabetes increases the risk of chronic liver disease and hepatocellular carcinoma","volume":"126","author":"El-Serag","year":"2004","journal-title":"Gastroenterology"},{"issue":"5","key":"10.1016\/j.jns.2016.02.018_bb0155","doi-asserted-by":"crossref","first-page":"115","DOI":"10.2337\/diaclin.23.3.115","article-title":"Elevated liver function tests in type 2 diabetes","volume":"23","author":"Harris","year":"2005","journal-title":"Clin. Diab."},{"issue":"Suppl. 1","key":"10.1016\/j.jns.2016.02.018_bb0160","doi-asserted-by":"crossref","first-page":"S81","DOI":"10.2337\/dc14-S081","article-title":"Diagnosis and classification of diabetes mellitus","volume":"37","author":"American Diabetes","year":"2014","journal-title":"Diabetes Care"},{"issue":"9","key":"10.1016\/j.jns.2016.02.018_bb0165","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1002\/j.1552-4604.1994.tb04002.x","article-title":"Lack of hepatotoxicity with naltrexone treatment","volume":"34","author":"Sax","year":"1994","journal-title":"J. Clin. Pharmacol."},{"issue":"10","key":"10.1016\/j.jns.2016.02.018_bb0170","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1007\/s004150170071","article-title":"Riluzole in Huntington's disease (HD): an open label study with one year follow up","volume":"248","author":"Seppi","year":"2001","journal-title":"J. Neurol."},{"issue":"Supplemental 1","key":"10.1016\/j.jns.2016.02.018_bb0175","first-page":"304","article-title":"Osteoporosis in Huntington's disease","volume":"4","author":"Otti","year":"2007","journal-title":"Neurodegener. Dis."},{"issue":"Issue 2 Supplement","key":"10.1016\/j.jns.2016.02.018_bb0180","first-page":"S64","article-title":"Bone density and bone turnover in Huntington's disease","volume":"12","author":"Bonelli","year":"2002","journal-title":"Osteoporos. Int."},{"key":"10.1016\/j.jns.2016.02.018_bb0185","first-page":"3","article-title":"Body composition in premanifest Huntington's disease reveals lower bone density compared to controls","author":"Goodman","year":"2011","journal-title":"PLoS Curr."},{"issue":"1","key":"10.1016\/j.jns.2016.02.018_bb0190","doi-asserted-by":"crossref","first-page":"125","DOI":"10.3233\/JHD-130049","article-title":"A critical evaluation of inflammatory markers in Huntington's disease plasma","volume":"2","author":"Silajdzic","year":"2013","journal-title":"J. Huntingtons Dis."},{"key":"10.1016\/j.jns.2016.02.018_bb0195","doi-asserted-by":"crossref","first-page":"231","DOI":"10.3389\/fphys.2014.00231","article-title":"Metabolic and hormonal signatures in pre-manifest and manifest Huntington's disease patients","volume":"5","author":"Wang","year":"2014","journal-title":"Front. Physiol."},{"issue":"7","key":"10.1016\/j.jns.2016.02.018_bb0200","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1179\/1743132812Y.0000000073","article-title":"Oxidative stress and inflammation biomarkers in the blood of patients with Huntington's disease","volume":"34","author":"Sanchez-Lopez","year":"2012","journal-title":"Neurol. Res."},{"issue":"3","key":"10.1016\/j.jns.2016.02.018_bb0205","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1111\/j.1471-4159.2005.03070.x","article-title":"Tryptophan metabolism and oxidative stress in patients with Huntington's disease","volume":"93","author":"Stoy","year":"2005","journal-title":"J. Neurochem."},{"issue":"8","key":"10.1016\/j.jns.2016.02.018_bb0210","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1016\/j.euroneuro.2014.05.004","article-title":"Acute-phase proteins in relation to neuropsychiatric symptoms and use of psychotropic medication in Huntington's disease","volume":"24","author":"Bouwens","year":"2014","journal-title":"Eur. Neuropsychopharmacol."},{"issue":"3","key":"10.1016\/j.jns.2016.02.018_bb0215","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.ymgme.2007.10.002","article-title":"Low plasma total cholesterol in patients with Huntington's disease and first-degree relatives","volume":"93","author":"Markianos","year":"2008","journal-title":"Mol. Genet. Metab."},{"issue":"Pt 11","key":"10.1016\/j.jns.2016.02.018_bb0220","doi-asserted-by":"crossref","first-page":"2851","DOI":"10.1093\/brain\/awn212","article-title":"Plasma 24S-hydroxycholesterol and caudate MRI in pre-manifest and early Huntington's disease","volume":"131","author":"Leoni","year":"2008","journal-title":"Brain"},{"issue":"5","key":"10.1016\/j.jns.2016.02.018_bb0225","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1136\/jnnp.2010.208553","article-title":"Growth hormone response to arginine test differentiates between two subgroups of Huntington's disease patients","volume":"82","author":"Salvatore","year":"2011","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.jns.2016.02.018_bb0230","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1136\/jnnp.38.10.1000","article-title":"Hepatic morphology in Huntington's chorea","volume":"39","author":"Chiu","year":"1975","journal-title":"J. Neurol. Psychopathol."},{"issue":"XLII","key":"10.1016\/j.jns.2016.02.018_bb0235","first-page":"151","article-title":"Huntington's chorea \u2014 a study of liver function and histology.","volume":"165","author":"Bolt","year":"1973","journal-title":"Quart. J. Med. New Ser."},{"issue":"5","key":"10.1016\/j.jns.2016.02.018_bb0240","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1093\/hmg\/ddi053","article-title":"The R6\/2 transgenic mouse model of Huntington's disease develops diabetes due to deficient beta-cell mass and exocytosis","volume":"14","author":"Bjorkqvist","year":"2005","journal-title":"Hum. Mol. Genet."},{"issue":"3","key":"10.1016\/j.jns.2016.02.018_bb0245","doi-asserted-by":"crossref","first-page":"649","DOI":"10.2337\/diabetes.48.3.649","article-title":"Mice transgenic for an expanded CAG repeat in the Huntington's disease gene develop diabetes","volume":"48","author":"Hurlbert","year":"1999","journal-title":"Diabetes"},{"issue":"1\u20132","key":"10.1016\/j.jns.2016.02.018_bb0250","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/S0166-4328(01)00261-3","article-title":"Evaluation of R6\/2 HD transgenic mice for therapeutic studies in Huntington's disease: behavioral testing and impact of diabetes mellitus","volume":"126","author":"Luesse","year":"2001","journal-title":"Behav. Brain Res."},{"issue":"9","key":"10.1016\/j.jns.2016.02.018_bb0255","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1111\/j.1365-2826.2009.01898.x","article-title":"Huntington's disease does not appear to increase the risk of diabetes mellitus","volume":"21","author":"Boesgaard","year":"2009","journal-title":"J. Neuroendocrinol."},{"issue":"4","key":"10.1016\/j.jns.2016.02.018_bb0260","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1001\/archneur.65.4.476","article-title":"Glucose homeostasis in Huntington disease: abnormalities in insulin sensitivity and early-phase insulin secretion","volume":"65","author":"Lalic","year":"2008","journal-title":"Arch. Neurol."},{"issue":"4","key":"10.1016\/j.jns.2016.02.018_bb0265","doi-asserted-by":"crossref","first-page":"501","DOI":"10.3233\/JHD-130078","article-title":"Insulin sensitivity and early-phase insulin secretion in normoglycemic Huntington's disease patients","volume":"2","author":"Russo","year":"2013","journal-title":"J. Huntingtons Dis."},{"issue":"5","key":"10.1016\/j.jns.2016.02.018_bb0270","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1177\/0091270010368678","article-title":"Effect of antipsychotic medications on glucose and lipid levels","volume":"51","author":"Chaggar","year":"2011","journal-title":"J. Clin. Pharmacol."},{"issue":"2\u20133","key":"10.1016\/j.jns.2016.02.018_bb0275","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.schres.2010.07.012","article-title":"Head-to-head comparisons of metabolic side effects of second generation antipsychotics in the treatment of schizophrenia: a systematic review and meta-analysis","volume":"123","author":"Rummel-Kluge","year":"2010","journal-title":"Schizophr. Res."},{"issue":"4","key":"10.1016\/j.jns.2016.02.018_bb0280","doi-asserted-by":"crossref","first-page":"547","DOI":"10.4088\/JCP.v65n0415","article-title":"Hyperlipidemia in persons using antipsychotic medication: a general population-based birth cohort study","volume":"65","author":"Saari","year":"2004","journal-title":"J. Clin. Psychiat."},{"issue":"4","key":"10.1016\/j.jns.2016.02.018_bb0285","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1530\/eje.0.1510451","article-title":"Circulating and cerebrospinal fluid ghrelin and leptin: potential role in altered body weight in Huntington's disease","volume":"151","author":"Popovic","year":"2004","journal-title":"Eur. J. Endocrinol."},{"issue":"9","key":"10.1016\/j.jns.2016.02.018_bb0290","doi-asserted-by":"crossref","first-page":"1618","DOI":"10.1345\/aph.1G293","article-title":"Hyponatremia associated with selective serotonin-reuptake inhibitors in older adults","volume":"40","author":"Jacob","year":"2006","journal-title":"Ann. Pharmacother."},{"issue":"1","key":"10.1016\/j.jns.2016.02.018_bb0295","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/j.neuroimage.2012.07.009","article-title":"Increased brain tissue sodium concentration in Huntington's Disease \u2014 a sodium imaging study at 4T","volume":"63","author":"Reetz","year":"2012","journal-title":"NeuroImage"},{"issue":"8\u20139","key":"10.1016\/j.jns.2016.02.018_bb0300","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1016\/j.exger.2005.06.009","article-title":"Age-related changes in liver structure and function: Implications for disease?","volume":"40","author":"Schmucker","year":"2005","journal-title":"Exp. Gerontol."},{"issue":"1","key":"10.1016\/j.jns.2016.02.018_bb0305","first-page":"1","article-title":"Liver diseases in the older adult","volume":"73","author":"Michielsen","year":"2010","journal-title":"Acta Gastroenterol. Belg."},{"issue":"6","key":"10.1016\/j.jns.2016.02.018_bb0310","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1093\/clinchem\/38.6.1167","article-title":"Laboratory values in fit aging individuals\u2014sexagenarians through centenarians","volume":"38","author":"Tietz","year":"1992","journal-title":"Clin. Chem."},{"issue":"4","key":"10.1016\/j.jns.2016.02.018_bb0315","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1176\/appi.ajp.2013.13050709","article-title":"Antidepressant-induced liver injury: a review for clinicians","volume":"171","author":"Voican","year":"2014","journal-title":"Am. J. Psychiatry"},{"issue":"5","key":"10.1016\/j.jns.2016.02.018_bb0320","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1097\/WNF.0b013e31826818b6","article-title":"Antipsychotics and abnormal liver function tests: systematic review","volume":"35","author":"Marwick","year":"2012","journal-title":"Clin. Neuropharmacol."},{"issue":"45","key":"10.1016\/j.jns.2016.02.018_bb0325","doi-asserted-by":"crossref","first-page":"5651","DOI":"10.3748\/wjg.v16.i45.5651","article-title":"Non-steroidal anti-inflammatory drugs: what is the actual risk of liver damage?","volume":"16","author":"Bessone","year":"2010","journal-title":"World J. Gastroenterol."},{"issue":"12","key":"10.1016\/j.jns.2016.02.018_bb0330","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1038\/nrn3587","article-title":"Hepatic encephalopathy: effects of liver failure on brain function","volume":"14","author":"Felipo","year":"2013","journal-title":"Nat. Rev. Neurosci."},{"issue":"11","key":"10.1016\/j.jns.2016.02.018_bb0335","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1016\/S1474-4422(15)00177-5","article-title":"Treating the whole body in Huntington's disease","volume":"14","author":"Carroll","year":"2015","journal-title":"Lancet Neurol."}],"container-title":["Journal of the Neurological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022510X16300831?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022510X16300831?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,4,4]],"date-time":"2021-04-04T23:25:19Z","timestamp":1617578719000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022510X16300831"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,3]]},"references-count":67,"alternative-id":["S0022510X16300831"],"URL":"https:\/\/doi.org\/10.1016\/j.jns.2016.02.018","relation":{},"ISSN":["0022-510X"],"issn-type":[{"value":"0022-510X","type":"print"}],"subject":[],"published":{"date-parts":[[2016,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Liver function in Huntington's disease assessed by blood biochemical analyses in a clinical setting","name":"articletitle","label":"Article Title"},{"value":"Journal of the Neurological Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jns.2016.02.018","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2016 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}